Obesity Surgery

, Volume 29, Issue 4, pp 1436–1438 | Cite as

Laparoscopic Sleeve Gastrectomy After Orthotopic Liver Transplantation, Video Reported

  • Georges Bou NassifEmail author
  • Chady Salloum
  • Luca Paolino
  • Daniel Azoulay
  • Andrea Lazzati
Video Submission



The immunosuppressive therapy for life after liver transplantation (LT) is considered as a risk factor for obesity. Seven percent of the transplanted patients develop severe or morbid obesity. The obesity induces non-alcoholic steatohepatitis (NASH), which is a major risk factor for liver cirrhosis and hepatocellular carcinoma, without forgetting the cardiovascular risk and the devastating impact of obesity on quality of life of the transplanted patients. Consequently, obesity exposes these patients to future transplant loss. Bariatric surgery has been proposed for transplant patients to reduce the obesity-related comorbidities and to improve survival. We report in this video the surgical technique of laparoscopic sleeve gastrectomy (LSG) after LT.


We have performed between 2008 and 2017 the sleeve gastrectomy (SG) after LT in nine patients. Six procedures (66%) were performed totally by laparoscopy and three by upfront laparotomy. All the patients had a standard preoperative evaluation for obesity. All the procedures were assisted by a hepatic surgeon. Postoperatively patients were transferred to the liver ICU for 24 h then to the liver unit ward.


The median BMI was 41.9 kg/m2 (range 38–46.1 kg/m2). Median operative time was 120 min (range, 90–240 min). No intra-operative complications occurred. The median length of hospital stay was 7 days (range, 4–81 days). The postoperative course of the majority of the patients was uneventful except for one patient who develops a staple line leak.


LSG after LT is technically feasible. Larger series are needed to improve the safety of the procedure in this high-risk population.


Steatohepatitis Bariatric surgery Sleeve gastrectomy Liver transplantation 


Compliance with Ethical Standards

Ethical Approval

The procedure was performed in accordance with the ethical standards of the institutional and the national research committee.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Informed Consent

Informed consent was obtained from the individual participant included in the study.


  1. 1.
    Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994–2009. Department of Health and Human Services, Health Resources and Services Administration, Healthca. Available from:
  2. 2.
    Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin Liver Dis. 2004;24(4):371–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance. J Obes. 2013;2013:839275.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    D’Amico G, Tulla K, Tzvetanov I. Bariatric Surgery and Transplantation. Glob Bariatric Surg. 2018;471–478
  5. 5.
    Lazzati A, Iannelli A, Schneck A-S, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.CrossRefPubMedGoogle Scholar
  6. 6.
    Elli EF, Gonzalez-Heredia R, Sanchez-Johnsen L, et al. Sleeve gastrectomy surgery in obese patients post-organ transplantation. Surg Obes Relat Dis. 2015;Google Scholar
  7. 7.
    Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg. 2007;17(11):1517–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Heimbach JK, Watt KDS, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13(2):363–8.CrossRefPubMedGoogle Scholar
  9. 9.
    LavilleM RM, Chavrier G, et al. Recommendations regarding obesity surgery. Obes Surg. 2005;15(10):1476–80.CrossRefGoogle Scholar
  10. 10.
    Lin MYC, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Khoraki J, Katz MG, Funk LM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2015;12(1):75–83.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of General SurgeryCenter Hospitalier Intercommunal de CréteilCréteilFrance
  2. 2.Service de Chirurgie Digestive, Hépato-BiliaireHôpital Henri-Mondor - AP-HPCréteilFrance

Personalised recommendations